| 1. |
News in brief ... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 2. |
Diabetes mellitus: a 'CHD risk equivalent'? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 3-4
Charles Bankhead,
Preview
|
|
摘要:
Increased awareness of the coronary risk associated with diabetes mellitus has sparked a call for consideration of diabetes as a 'coronary heart disease (CHD) risk equivalent' and for adoption of a secondary prevention mode for management of dyslipidaemia in such patients. Patients with diabetes who do not have evidence of CHD have the same cardiovascular risk as patients who have a history of myocardial infarction (MI).1Furthermore, lipid levels, and LDL-cholesterol levels in particular, have proved to be an especially potent predictor of cardiovascular risk in patients with diabetes, perhaps even more potent than in patients without diabetes.2The American Diabetes Association (ADA) recommends an LDL-cholesterol level of less than 100 mg/dl for all patients with diabetes and further recommends aggressive use of lipid-lowering drugs to achieve this goal.*At Prevention VI: Diabetes and Cardiovascular Disease [Orlando, US; January 2001], a panel of experts in preventive cardiology and diabetes convened by the American Heart Association (AHA) added its support to aggressive lipid-lowering therapy in patients with diabetes, including consideration of drug therapy for patients with LDL-cholesterol levels in the 'gray area' of 100-129 mg/dl.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 3. |
News in brief ... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 4. |
Microbicides for preventing HIV infection? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 5. |
Abciximab:'economic attractiveness'enhanced with low-dose heparin |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 6. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 7. |
Fondaparin sodium offers new standard in VTE prophylaxis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 8-9
Larry Prescott,
Preview
|
|
摘要:
Fondaparin sodium, the first of a new class of synthetic, highly selective factor Xa inhibitors, holds great promise as a new standard of care in the prevention of venous thromboembolism (VTE). Data from a phase II dose-ranging study and 4 comparative phase III clinical trials demonstrating the value of this novel antithrombotic agent were presented at the 35th American Society of Health-System Pharmacists Midyear Clinical Meeting [Las Vegas, US; December 2000].
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 8. |
Novel cancer vaccine news... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 9. |
News in brief... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
| 10. |
Promising haematological gene therapies progress to the clinic |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1276,
2001,
Page 11-12
Sushma Soni,
Preview
|
|
摘要:
The rapidly growing field of gene therapy is branching out into many different therapeutic areas. Despite some setbacks, such therapy is still thought to hold great promise, particularly in disorders resulting from genetic abnormalities. At the 42nd Annual Meeting of the American Society of Hematology [San Francisco, US; December 2000], positive clinical study results were presented which demonstrate the beneficial effects of factor VIII gene therapy in patients with haemophilia A and SCID gene therapy in infants with severe combined immunodeficiency (SCID)-X1 disease.*
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
首页
